S

Shanghai Rendu Biotechnology Co Ltd
SSE:688193

Watchlist Manager
Shanghai Rendu Biotechnology Co Ltd
SSE:688193
Watchlist
Price: 51.83 CNY -0.19% Market Closed
Market Cap: ¥2.1B

Relative Value

The Relative Value of one Shanghai Rendu Biotechnology Co Ltd stock under the Base Case scenario is hidden CNY. Compared to the current market price of 51.83 CNY, Shanghai Rendu Biotechnology Co Ltd is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Shanghai Rendu Biotechnology Co Ltd Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Multiples Across Competitors

Competitors Multiples
Shanghai Rendu Biotechnology Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Shanghai Rendu Biotechnology Co Ltd
SSE:688193
2.1B CNY 12 -201.4 -59.8 -59.8
US
Medline Inc
NASDAQ:MDLN
58.5B USD 0 0 0 0
JP
Hoya Corp
TSE:7741
9.1T JPY 9.9 36.4 26.3 31.5
CH
Alcon AG
SIX:ALC
30.1B CHF 3.8 37.4 15.4 30.1
DK
Coloplast A/S
CSE:COLO B
120.8B DKK 4.3 33.2 15.3 18.2
US
Align Technology Inc
NASDAQ:ALGN
12.7B USD 3.2 33.6 15.3 19.4
UK
ConvaTec Group PLC
LSE:CTEC
4.7B GBP 2.7 29.7 13.2 21.4
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
42.9B CNY 9.4 26 23.5 23.5
CA
Bausch + Lomb Corp
NYSE:BLCO
5.9B USD 1.2 -19.1 19.2 90.7
CH
Ypsomed Holding AG
SIX:YPSN
4B CHF 5.1 20.7 13.4 18.2
KR
HLB Inc
KOSDAQ:028300
7.2T KRW 85 -31.2 -72.3 -68.4
P/E Multiple
Earnings Growth PEG
CN
S
Shanghai Rendu Biotechnology Co Ltd
SSE:688193
Average P/E: 31
Negative Multiple: -201.4
N/A N/A
US
M
Medline Inc
NASDAQ:MDLN
Not Available N/A N/A
JP
Hoya Corp
TSE:7741
36.4
13%
2.8
CH
Alcon AG
SIX:ALC
37.4
25%
1.5
DK
Coloplast A/S
CSE:COLO B
33.2
22%
1.5
US
Align Technology Inc
NASDAQ:ALGN
33.6
27%
1.2
UK
ConvaTec Group PLC
LSE:CTEC
29.7
33%
0.9
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
26
9%
2.9
CA
Bausch + Lomb Corp
NYSE:BLCO
Negative Multiple: -19.1 N/A N/A
CH
Ypsomed Holding AG
SIX:YPSN
20.7
32%
0.6
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -31.2 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CN
S
Shanghai Rendu Biotechnology Co Ltd
SSE:688193
Average EV/EBITDA: 17.7
Negative Multiple: -59.8
N/A N/A
US
M
Medline Inc
NASDAQ:MDLN
Not Available N/A N/A
JP
Hoya Corp
TSE:7741
26.3
11%
2.4
CH
Alcon AG
SIX:ALC
15.4
8%
1.9
DK
Coloplast A/S
CSE:COLO B
15.3
8%
1.9
US
Align Technology Inc
NASDAQ:ALGN
15.3
13%
1.2
UK
ConvaTec Group PLC
LSE:CTEC
13.2
10%
1.3
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
23.5
15%
1.6
CA
Bausch + Lomb Corp
NYSE:BLCO
19.2
21%
0.9
CH
Ypsomed Holding AG
SIX:YPSN
13.4
21%
0.6
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -72.3 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CN
S
Shanghai Rendu Biotechnology Co Ltd
SSE:688193
Average EV/EBIT: 31.6
Negative Multiple: -59.8
N/A N/A
US
M
Medline Inc
NASDAQ:MDLN
Not Available N/A N/A
JP
Hoya Corp
TSE:7741
31.5
N/A N/A
CH
Alcon AG
SIX:ALC
30.1
23%
1.3
DK
Coloplast A/S
CSE:COLO B
18.2
8%
2.3
US
Align Technology Inc
NASDAQ:ALGN
19.4
16%
1.2
UK
ConvaTec Group PLC
LSE:CTEC
21.4
22%
1
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
23.5
11%
2.1
CA
Bausch + Lomb Corp
NYSE:BLCO
90.7
60%
1.5
CH
Ypsomed Holding AG
SIX:YPSN
18.2
29%
0.6
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -68.4 N/A N/A